Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Cancer Diagnostics"

14:29 EDT 28th July 2014 | BioPortfolio

Original Source: Lab21 Launches New Lung Cancer Diagnostic Service

Cambridge, UK – 16 February 2012 - Lab21 Limited, the global specialist in personalised medicine and clinical diagnostics has launched a new Companion Diagnostic testing service for non-small cell lung cancer patients. The EML4-ALK companion diagnostic test for translocations in the ALK gene will allow physicians to select lung cancer patients likely to respond to ALK inhibitor therapy. The test uses proprietary PCR technology and will be performed in Lab21’s accredited laboratories in...

Matching Channels


Roche is the 5th largest pharmaceutical company in the world, based on annual sales, which were recorded at $36,017m in 2009. The pharmaceutical products of Roche are major players in the followin...

Genitourinary Cancer

Nasopharyngeal Cancer

Laryngeal Cancer

Vulvar Cancer

Matching News

Cancer therapy and cancer diagnostics

Thanks to improved diagnostics and therapy, today’s cancer patients can live considerably longer than patients several years ago. Nevertheless, some cancers, especially the strongly metastatic ones,...

GeneNews raises $Cdn7.2mm through private placement

GeneNews Ltd. (molecular diagnostics for cancer) grossed $Cdn7.2mm ($6.7mm) through the private sale of 7mm common shares at $Cdn1.03, a 13% discount. The company will use the proceeds to help its US-...

PointMan enriches low-level DNA mutations from whole blood

Ultra-sensitive PointMan™ enables blood sampling instead of tissue biopsies for cancer patient mutation status assessment EKF Diagnostics, the global in vitro diagnostics business, an...

Memorial Sloan Kettering Cancer Center, Quest Diagnostics partner for cancer tests

Memorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center, and Quest Diagnostics, the world's leading provider of diagnostic information services, today announced a...

Accelerating the development of new cancer therapies; Ketil Widerberg, General Manager, Oslo Cancer Cluster

Four out of ten people will be diagnosed with cancer during their life and it is crucial to develop new diagnostics and medication. Oslo Cancer Cluster is an oncology research and industry cluster de...

Memorial Sloan Kettering and Quest Form Strategic Alliance

Here's news about an interesting new collaboration between Memorial Sloan Kettering Cancer Center and Quest Diagnostics (see: Memorial Sloan Kettering Cancer Center and Quest Diagnostics Partner to Ad...

Personal Genome Diagnostics raises $2.8mm through first venture round

Cancer testing company Personal Genome Diagnostics Inc. (PGDx) reached out to investors for the first time, raising $2.8mm through a Series A round from undisclosed private buyers. Since its 2010 ince...

Memorial Sloan Kettering Cancer Center, Quest Diagnostics partner

Memorial Sloan Kettering (MSK) Cancer Center and Quest Diagnostics, a provider of diagnostic information services, have formed a joint collaboration that will utilize MSK's clinical and research insig...

Matching PubMed Articles

Innovations in Cervical and Endometrial Cancer.

The S2k guideline "Diagnostics and Therapy for Cervical Cancer" published in 2008 is currently being revised to the S3 level. Current developments in epidemiology, surgical therapy, radiochemotherapy...

Structured diagnostics and therapy of the CUP syndrome.

In the majority of cases, patients with cancer of unknown primary (CUP) have a poor prognosis with no prospect of being cured. Hence, a reasonable focus of diagnostics on its essential targets seems a...

From the guest editor: into the era of personalized cancer diagnostics.

Anticipating Precision Medicine's Future.

Instead of investing in technologies to test a few genes at a time, researchers and regulators should plan for the routine use whole-genome sequencing in the diagnosis of cancer, according to speakers...

Criteria of the molecular pathology testing of lung cancer.

From the aspect of the contemporary pathologic diagnostics of lung cancer the tissue obtained is a key issue since small biopsies and cytology still play a major role. In the non-small cell lung cance...

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement